135 related articles for article (PubMed ID: 35397254)
1. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
[TBL] [Abstract][Full Text] [Related]
2. New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.
Walker A; Mrózek K; Kohlschmidt J; Rao KW; Pettenati MJ; Sterling LJ; Marcucci G; Carroll AJ; Bloomfield CD;
Genes Chromosomes Cancer; 2013 Apr; 52(4):385-401. PubMed ID: 23225546
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
4. 8;21 translocation in myelodysplasia secondary to essential thrombocythemia.
Knottenbelt E; Hallett J; Jacobs P
Am J Hematol; 1989 Apr; 30(4):233-5. PubMed ID: 2929582
[TBL] [Abstract][Full Text] [Related]
5. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome with fibrosis and complex karyotype arising in a patient with essential thrombocythaemia.
Mansor NA; Yusof N; Tang YL; Ithnin A; Azma RZ; Tumian NR; Shuib S
Malays J Pathol; 2018 Aug; 40(2):191-197. PubMed ID: 30173238
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic Syndrome with concomitant t(5;21)(q15;q22) and del(5)(q13q33): case report and review of literature.
Kasi Loknath Kumar A; Weckbaugh B; Sirridge C; Woodroof J; Persons D; Kambhampati S
Stem Cell Investig; 2016; 3():3. PubMed ID: 27358895
[TBL] [Abstract][Full Text] [Related]
8. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
9. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic Syndrome with t(1;14),t(1;17),t(1;19) Transforms to AML-M5: A Case Report and Literature Review.
Zhang H; Li G; Chang J; Wang H
Ann Clin Lab Sci; 2020 May; 50(3):401-403. PubMed ID: 32581034
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.
Sever M; Kantarjian H; Pierce S; Jain N; Estrov Z; Cortes J; Verstovsek S
Int J Hematol; 2009 Nov; 90(4):522-525. PubMed ID: 19728024
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
Zhang LJ; Shin ES; Yu ZX; Li SB
Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
[TBL] [Abstract][Full Text] [Related]
14. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
Hernández JM; Granada I; Solé F;
Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
[TBL] [Abstract][Full Text] [Related]
15. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
Lin P; Medeiros LJ; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
Jotterand M; Parlier V
Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
18. MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities.
Park TS; Lee ST; Song J; Lee KA; Lee SG; Kim J; Suh B; Kim SJ; Lee JH; Park R; Choi JR
Cancer Genet Cytogenet; 2008 Nov; 187(1):50-3. PubMed ID: 18992643
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
20. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]